Chip stocks fall with Nvidia after data center rev disappointment
Investing.com - Immunome reported on Monday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Immunome announced earnings per share of $-0.75 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.79 on revenue of $0.00.
Immunome 's are down 67% and is trading at $4.14 , still down 78.93% from its 52 week high of $19.65 set on Tuesday, November 30, 2021.
Immunome shares lost 0.72% to trade at $4.14 in intra-day trade the report.
Immunome follows other major Healthcare sector earnings this month
Immunome's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar